Yi-Hsiang Liu
2PUBLICATIONS
0CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (2)
Sort by Publication Date:
|Apr 16, 2021
Sorafenib combined with dasatinib therapy inhibits cell viability, migration, and angiogenesis synergistically in hepatocellular carcinoma.Chiung-Chi Cheng, Wei-Ting Chao, Jing-Hao Shih
|Oct 22, 2019
The Roles Of Angiogenesis And Cancer Stem Cells In Sorafenib Drug Resistance In Hepatocellular Carcinoma.Chiung-Chi Cheng, Wei-Ting Chao, Chen-Chun Liao
Pageof 1
